All three are very large markets indeed:
Corticosteroids - Estimated $5 B 1
Viscosupplementation - Estimated $4.4 B 2
And the grand-daddy of them all:
Opioids - Estimated $22 B 3
The above three are only symptomatic relief strategies, none of those have any affect whatsoever on the positive course of the disease, in fact they can in some cases lead to a worsening of the underlying disease.
Yes will take some time to slowly bite into these markets but certainly with a DMOAD, that will ramp up our progressive market share once we are out there selling.
Ref
1 https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report#:~:text=The%20global%20corticosteroids%20market%20grew,least%20in%20the%20short%20term.
2 https://au.finance.yahoo.com/news/viscosupplementation-market-valued-us-4-131000209.html#:~:text=New%20York%2C%20Jan.,published%20Persistence%20Market%20Research%20report.
3 https://www.grandviewresearch.com/industry-analysis/opioids-market
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-3494
-
- There are more pages in this discussion • 695 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $104.9M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 62010 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10756 | 0.300 |
1 | 99965 | 0.295 |
5 | 87991 | 0.290 |
3 | 38593 | 0.285 |
3 | 110000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 50010 | 2 |
0.320 | 45000 | 2 |
0.325 | 50366 | 4 |
0.330 | 125773 | 4 |
0.335 | 10000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online